Challenges of alloimmunization in patients with haemoglobinopathies

British Journal of Haematology

Volumn 159, Issue 4, 2012, Pages 394-404

  Chou, Stella T ^a   Liem, Robert I ^b   Thompson, Alexis A ^b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

Alloimmunization; Haemoglobinopathies; Sickle cell disease; Thalassaemia; Transfusion

Indexed keywords

ALLOANTIBODY; CORTICOSTEROID; IMMUNOGLOBULIN; RITUXIMAB; STEROID;

ALLOIMMUNIZATION; ANTIBODY PRODUCTION; ANTIGEN SPECIFICITY; BLOOD DONOR; BLOOD GROUP RHESUS SYSTEM; BLOOD GROUP TYPING; BLOOD STORAGE; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; DONOR SELECTION; DRUG MEGADOSE; ERYTHROCYTE; GENETIC VARIABILITY; GENOTYPE; HEMOGLOBINOPATHY; HIGH RISK POPULATION; HUMAN; IMMUNOMODULATION; LEUKAPHERESIS; PATHOPHYSIOLOGY; PATIENT MONITORING; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SICKLE CELL ANEMIA; SINGLE NUCLEOTIDE POLYMORPHISM; THALASSEMIA;

ANEMIA, SICKLE CELL; ANIMALS; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; HEMOGLOBINOPATHIES; HUMANS; ISOANTIBODIES; PREVALENCE; RISK FACTORS; THALASSEMIA;

EID: 84868213735     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12061     Document Type: Review

References (107)

1. Afenyi-Annan, A. & Bandarenko, N. (2006) Transfusion practices for patients with sickle cell disease at a major academic medical center. Immunohematology, 22, 103-107.
2. Afenyi-Annan, A., Willis, M.S., Konrad, T.R. & Lottenberg, R. (2007) Blood bank management of sickle cell patients at comprehensive sickle cell centers. Transfusion, 47, 2089-2097.
3. Alarif, L., Castro, O., Ofosu, M., Dunston, G. & Scott, R.B. (1986) HLA-B35 is associated with red cell alloimmunization in sickle cell disease. Clinical Immunology and Immunopathology, 38, 178-183.
4. Ambruso, D.R., Githens, J.H., Alcorn, R., Dixon, D.J., Brown, L.J., Vaughn, W.M. & Hays, T. (1987) Experience with donors matched for minor blood group antigens in patients with sickle cell anemia who are receiving chronic transfusion therapy. Transfusion, 27, 94-98.
5. Ameen, R., Al-Shemmari, S., Al-Humood, S., Chowdhury, R.I., Al-Eyaadi, O. & Al-Bashir, A. (2003) RBC alloimmunization and autoimmunization among transfusion-dependent Arab thalassemia patients. Transfusion, 43, 1604-1610.
6. Ameen, R., Al Shemmari, S. & Al-Bashir, A. (2009) Red blood cell alloimmunization among sickle cell Kuwaiti Arab patients who received red blood cell transfusion. Transfusion, 49, 1649-1654.
7. Anderson, R.R., Sosler, S.D., Kovach, J. & DeChristopher, P.J. (1997) Delayed hemolytic transfusion reaction due to anti-Js(a) in an alloimmunized patient with a sickle cell syndrome. American Journal of Clinical Pathology, 108, 658-661.
8. Anstee, D.J. (2009) Red cell genotyping and the future of pretransfusion testing. Blood, 114, 248-256.
9. Aygun, B., Padmanabhan, S., Paley, C. & Chandrasekaran, V. (2002) Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion, 42, 37-43.
10. Azarkeivan, A., Ansari, S., Ahmadi, M.H., Hajibeigy, B., Maghsudlu, M., Nasizadeh, S., Shaigan, M., Toolabi, A. & Salahmand, M. (2011) Blood transfusion and alloimmunization in patients with thalassemia: multicenter study. Pediatric Hematology and Oncology, 28, 479-485.
11. Bachmeyer, C., Maury, J., Parrot, A., Bachir, D., Stankovic, K., Girot, R. & Lionnet, F. (2010) Rituximab as an effective treatment of hyperhemolysis syndrome in sickle cell anemia. American Journal of Hematology, 85, 91-92.
12. Baek, J.H., D'Agnillo, F., Vallelian, F., Pereira, C.P., Williams, M.C., Jia, Y., Schaer, D.J. & Buehler, P.W. (2012) Hemoglobin-driven pathophysiology is an in vivo consequence of the red blood cell storage lesion that can be attenuated in guinea pigs by haptoglobin therapy. J Clin Invest, 122, 1444-1458.
13. Bao, W., Zhong, H., Li, X., Lee, M.T., Schwartz, J., Sheth, S. & Yazdanbakhsh, K. (2011) Immune regulation in chronically transfused allo-antibody responder and nonresponder patients with sickle cell disease and beta-thalassemia major. American Journal of Hematology, 86, 1001-1006.
14. Bauer, M.P., Wiersum-Osselton, J., Schipperus, M., Vandenbroucke, J.P. & Briet, E. (2007) Clinical predictors of alloimmunization after red blood cell transfusion. Transfusion, 47, 2066-2071.
15. Blajchman, M.A. (2006) The clinical benefits of the leukoreduction of blood products. Journal of Trauma, 60, S83-S90.
16. Blumberg, N., Heal, J.M. & Gettings, K.F. (2003) WBC reduction of RBC transfusions is associated with a decreased incidence of RBC alloimmunization. Transfusion, 43, 945-952.
17. Bowen, D.T., Devenish, A., Dalton, J. & Hewitt, P.E. (1988) Delayed haemolytic transfusion reaction due to simultaneous appearance of anti-Fya and Anti-Fy5. Vox Sanguinis, 55, 35-36.
18. Brittain, J.E. & Parise, L.V. (2007) Cytokines and plasma factors in sickle cell disease. Current Opinion in Hematology, 14, 438-443.
19. Castellino, S.M., Combs, M.R., Zimmerman, S.A., Issitt, P.D. & Ware, R.E. (1999) Erythrocyte autoantibodies in paediatric patients with sickle cell disease receiving transfusion therapy: frequency, characteristics and significance. British Journal of Haematology, 104, 189-194.
20. Castro, O., Sandler, S.G., Houston-Yu, P. & Rana, S. (2002) Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications. Transfusion, 42, 684-690.
21. Chadebech, P., Habibi, A., Nzouakou, R., Bachir, D., Meunier-Costes, N., Bonin, P., Rodet, M., Chami, B., Galacteros, F., Bierling, P. & Noizat-Pirenne, F. (2009) Delayed hemolytic transfusion reaction in sickle cell disease patients: evidence of an emerging syndrome with suicidal red blood cell death. Transfusion, 49, 1785-1792.
22. Chaudhary, R. & Katharia, R. (2012) Oxidative injury as contributory factor for red cells storage lesion during twenty-eight days of storage. Blood Transfusion, 10, 59-62.
23. Cheng, C.K., Lee, C.K. & Lin, C.K. (2012) Clinically significant red blood cell antibodies in chronically transfused patients: a survey of Chinese thalassemia major patients and literature review. Transfusion, Feb 17. doi: 10.1111/j.1537-2995.2012.03570.x. [Epub ahead of print].
24. Chou, S.T. & Westhoff, C.M. (2010) The Rh and RhAG blood group systems. Immunohematology, 26, 178-186.
25. Chou, S.T. & Westhoff, C.M. (2011) The role of molecular immunohematology in sickle cell disease. Transfusion and Apheresis Science, 44, 73-79.
26. Cohen, A., Gayer, R. & Mizanin, J. (1989) Long-term effect of splenectomy on transfusion requirements in thalassemia major. American Journal of Hematology, 30, 254-256.
27. Cox, J.V., Steane, E., Cunningham, G. & Frenkel, E.P. (1988) Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease. Archives of Internal Medicine, 148, 2485-2489.
28. El-Danasoury, A.S., Eissa, D.G., Abdo, R.M. & Elalfy, M.S. (2012) Red blood cell alloimmunization in transfusion-dependent Egyptian patients with thalassemia in a limited donor exposure program. Transfusion, 52, 43-47.
29. Davies, S.C., McWilliam, A.C., Hewitt, P.E., Devenish, A. & Brozovic, M. (1986) Red cell alloimmunization in sickle cell disease. British Journal of Haematology, 63, 241-245.
30. Dias Zanette, A.M., de Souza Goncalves, M., Vilasboas Schettini, L., Magalhaes Aguiar, L., Santos Bahia, R.C., Vasconcelos Nogueira, L.A., de Freitas Brandao, C.J., Neves de Azevedo, A.C., Ramos de Aragao, L. & Marcos Arruda, S. (2010) Alloimmunization and clinical profile of sickle cell disease patients from Salvador-Brazil. Ethnicity and Disease, 20, 136-141.
31. Edgren, G., Kamper-Jorgensen, M., Eloranta, S., Rostgaard, K., Custer, B., Ullum, H., Murphy, E.L., Busch, M.P., Reilly, M., Melbye, M., Hjalgrim, H. & Nyren, O. (2010) Duration of red blood cell storage and survival of transfused patients (CME). Transfusion, 50, 1185-1195.
32. Elenga, N., Mialou, V., Kebaili, K., Galambrun, C., Bertrand, Y. & Pondarre, C. (2008) Severe neurologic complication after delayed hemolytic transfusion reaction in 2 children with sickle cell anemia: significant diagnosis and therapeutic challenges. Journal of Pediatric Hematology/Oncology, 30, 928-930.
33. Flickinger, C. (2006) In search of red blood cells for alloimmunized patients with sickle cell disease. Immunohematology, 22, 136-142.
34. Gader, A.G., Al Ghumlas, A.K. & Al-Momen, A.K. (2008) Transfusion medicine in a developing country - alloantibodies to red blood cells in multi-transfused patients in Saudi Arabia. Transfusion and Apheresis Science, 39, 199-204.
35. Godfrey, G.J., Lockwood, W., Kong, M., Bertolone, S. & Raj, A. (2010) Antibody development in pediatric sickle cell patients undergoing erythrocytapheresis. Pediatric Blood & Cancer, 55, 1134-1137.
36. Heddle, N.M., Soutar, R.L., O'Hoski, P.L., Singer, J., McBride, J.A., Ali, M.A. & Kelton, J.G. (1995) A prospective study to determine the frequency and clinical significance of alloimmunization post-transfusion. British Journal of Haematology, 91, 1000-1005.
37. Hendrickson, J.E., Desmarets, M., Deshpande, S.S., Chadwick, T.E., Hillyer, C.D., Roback, J.D. & Zimring, J.C. (2006) Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells. Transfusion, 46, 1526-1536.
38. Hendrickson, J.E., Hod, E.A., Spitalnik, S.L., Hillyer, C.D. & Zimring, J.C. (2010) Storage of murine red blood cells enhances alloantibody responses to an erythroid-specific model antigen. Transfusion, 50, 642-648.
39. Hendrickson, J.E., Hod, E.A., Perry, J.R., Ghosh, S., Chappa, P., Adisa, O., Kean, L.S., Ofori-Acquah, S.F., Archer, D.R., Spitalnik, S.L. & Zimring, J.C. (2012) Alloimmunization to transfused HOD red blood cells is not increased in mice with sickle cell disease. Transfusion, 52, 231-240.
40. Hillyer, K.L., Hare, V.W., Josephson, C.D., Harris, S.B. & Hillyer, C.D. (2006) Partners for life: the transfusion program for patients with sickle cell disease offered at the American Red Cross Blood Services, Southern Region, Atlanta, Georgia. Immunohematology, 22, 108-111.
41. Hillyer, C.D., Blumberg, N., Glynn, S.A. & Ness, P.M. (2008) Transfusion recipient epidemiology and outcomes research: possibilities for the future. Transfusion, 48, 1530-1537.
42. Hod, E.A., Zhang, N., Sokol, S.A., Wojczyk, B.S., Francis, R.O., Ansaldi, D., Francis, K.P., Della-Latta, P., Whittier, S., Sheth, S., Hendrickson, J.E., Zimring, J.C., Brittenham, G.M. & Spitalnik, S.L. (2010) Transfusion of red blood cells after prolonged storage produces harmful effects that are mediated by iron and inflammation. Blood, 115, 4284-4292.
43. Hoppe, C., Klitz, W., Vichinsky, E. & Styles, L. (2009) HLA type and risk of alloimmunization in sickle cell disease. American Journal of Hematology, 84, 462-464.
44. James, A.B., Hillyer, C.D. & Shaz, B.H. (2012) Demographic differences in estimated blood donor eligibility prevalence in the United States. Transfusion, 52, 1050-1061.
45. Kim-Shapiro, D.B., Lee, J. & Gladwin, M.T. (2011) Storage lesion: role of red blood cell breakdown. Transfusion, 51, 844-851.
46. King, K.E., Shirey, R.S., Lankiewicz, M.W., Young-Ramsaran, J. & Ness, P.M. (1997) Delayed hemolytic transfusion reactions in sickle cell disease: simultaneous destruction of recipients' red cells. Transfusion, 37, 376-381.
47. Koch, C.G., Li, L., Sessler, D.I., Figueroa, P., Hoeltge, G.A., Mihaljevic, T. & Blackstone, E.H. (2008) Duration of red-cell storage and complications after cardiac surgery. New England Journal of Medicine, 358, 1229-1239.
48. Kriebardis, A.G., Antonelou, M.H., Stamoulis, K.E., Economou-Petersen, E., Margaritis, L.H. & Papassideri, I.S. (2007) Storage-dependent remodeling of the red blood cell membrane is associated with increased immunoglobulin G binding, lipid raft rearrangement, and caspase activation. Transfusion, 47, 1212-1220.
49. Kriebardis, A.G., Antonelou, M.H., Stamoulis, K.E., Economou-Petersen, E., Margaritis, L.H. & Papassideri, I.S. (2008) RBC-derived vesicles during storage: ultrastructure, protein composition, oxidation, and signaling components. Transfusion, 48, 1943-1953.
50. Lasalle-Williams, M., Nuss, R., Le, T., Cole, L., Hassell, K., Murphy, J.R. & Ambruso, D.R. (2011) Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14-year experience from a single center. Transfusion, 51, 1732-1739.
51. de Montalembert, M., Dumont, M.D., Heilbronner, C., Brousse, V., Charrara, O., Pellegrino, B., Piguet, C., Soussan, V. & Noizat-Pirenne, F. (2011) Delayed hemolytic transfusion reaction in children with sickle cell disease. Haematologica, 96, 801-807.
52. Natukunda, B., Schonewille, H., Ndugwa, C. & Brand, A. (2010) Red blood cell alloimmunization in sickle cell disease patients in Uganda. Transfusion, 50, 20-25.
53. Noizat-Pirenne, F. & Tournamille, C. (2011) Relevance of RH variants in transfusion of sickle cell patients. Transfusion Clinique et Biologique, 18, 527-535.
54. Noizat-Pirenne, F., Lee, K., Pennec, P.Y., Simon, P., Kazup, P., Bachir, D., Rouzaud, A.M., Roussel, M., Juszczak, G., Menanteau, C., Rouger, P., Kotb, R., Cartron, J.P. & Ansart-Pirenne, H. (2002a) Rare RHCE phenotypes in black individuals of Afro-Caribbean origin: identification and transfusion safety. Blood, 100, 4223-4231.
55. Noizat-Pirenne, F., Le Pennec, P.Y., Mouro, I., Rouzaud, A.M., Juszczak, G., Roussel, M., Lauroua, P., Krause, C., Rouger, P., Cartron, J.P. & Ansart-Pirenne, H. (2002b) Molecular background of D(C)(e) haplotypes within the white population. Transfusion, 42, 627-633.
56. Noizat-Pirenne, F., Bachir, D., Chadebech, P., Michel, M., Plonquet, A., Lecron, J.C., Galacteros, F. & Bierling, P. (2007) Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell disease. Haematologica, 92, e132-e135.
57. Offner, P.J., Moore, E.E., Biffl, W.L., Johnson, J.L. & Silliman, C.C. (2002) Increased rate of infection associated with transfusion of old blood after severe injury. Archives of Surgery, 137, 711-716; discussion 716-717.
58. Olujohungbe, A., Hambleton, I., Stephens, L., Serjeant, B. & Serjeant, G. (2001) Red cell antibodies in patients with homozygous sickle cell disease: a comparison of patients in Jamaica and the United Kingdom. British Journal of Haematology, 113, 661-665.
59. Osby, M. & Shulman, I.A. (2005) Phenotype matching of donor red blood cell units for nonalloimmunized sickle cell disease patients: a survey of 1182 North American laboratories. Archives of Pathology and Laboratory Medicine, 129, 190-193.
60. Pahuja, S., Pujani, M., Gupta, S.K., Chandra, J. & Jain, M. (2010) Alloimmunization and red cell autoimmunization in multitransfused thalassemics of Indian origin. Hematology, 15, 174-177.
61. Petz, L.D., Calhoun, L., Shulman, I.A., Johnson, C. & Herron, R.M. (1997) The sickle cell hemolytic transfusion reaction syndrome. Transfusion, 37, 382-392.
62. Purdy, F.R., Tweeddale, M.G. & Merrick, P.M. (1997) Association of mortality with age of blood transfused in septic ICU patients. Canadian Journal of Anaesthesia, 44, 1256-1261.
63. Reid, M.E. & Lomas-Francis, C. (2004) The Blood Group Antigen Factsbook. Academic Press, San Diego, CA.
64. Reiter, C.D., Wang, X., Tanus-Santos, J.E., Hogg, N., Cannon, III, R.O., Schechter, A.N. & Gladwin, M.T. (2002) Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nature Medicine, 8, 1383-1389.
65. Relevy, H., Koshkaryev, A., Manny, N., Yedgar, S. & Barshtein, G. (2008) Blood banking-induced alteration of red blood cell flow properties. Transfusion, 48, 136-146.
66. Reyes, M.A. & Illoh, O.C. (2008) Hyperhemolytic transfusion reaction attributable to anti-Fy3 in a patient with sickle cell disease. Immunohematology, 24, 45-51.
67. Ribeiro, K.R., Guarnieri, M.H., da Costa, D.C., Costa, F.F., Pellegrino, Jr, J. & Castilho, L. (2009) DNA array analysis for red blood cell antigens facilitates the transfusion support with antigen-matched blood in patients with sickle cell disease. Vox Sanguinis, 97, 147-152.
68. Roberts, D.O., Covert, B., Lindsey, T., Edwards, V., McLaughlin, L., Theus, J., Wray, R.J., Jupka, K., Baker, D., Robbins, M. & Debaun, M.R. (2012) Directed blood donor program decreases donor exposure for children with sickle cell disease requiring chronic transfusion. Immunohematology, 28, 7-12.
69. Rosse, W.F., Gallagher, D., Kinney, T.R., Castro, O., Dosik, H., Moohr, J., Wang, W. & Levy, P.S. (1990) Transfusion and alloimmunization in sickle cell disease. The cooperative study of sickle cell disease. Blood, 76, 1431-1437.
70. Rother, R.P., Bell, L., Hillmen, P. & Gladwin, M.T. (2005) The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA, 293, 1653-1662.
71. Sakhalkar, V.S., Roberts, K., Hawthorne, L.M., McCaskill, D.M., Veillon, D.M., Caldito, G.C. & Cotelingam, J.D. (2005) Allosensitization in patients receiving multiple blood transfusions. Annals of the New York Academy of Sciences, 1054, 495-499.
72. Scheunemann, L.P. & Ataga, K.I. (2010) Delayed hemolytic transfusion reaction in sickle cell disease. American Journal of the Medical Sciences, 339, 266-269.
73. Schonewille, H. & Brand, A. (2005) Alloimmunization to red blood cell antigens after universal leucodepletion. A regional multicentre retrospective study. British Journal of Haematology, 129, 151-156.
74. Schonewille, H., Haak, H.L. & van Zijl, A.M. (1999) Alloimmunization after blood transfusion in patients with hematologic and oncologic diseases. Transfusion, 39, 763-771.
75. Schonewille, H., van de Watering, L.M., Loomans, D.S. & Brand, A. (2006) Red blood cell alloantibodies after transfusion: factors influencing incidence and specificity. Transfusion, 46, 250-256.
76. Sesok-Pizzini, D.A., Friedman, D.F., Smith-Whitley, K. & Nance, S.J. (2006) Transfusion support of patients with sickle cell disease at the Children's Hospital of Philadelphia. Immunohematology, 22, 121-125.
77. Sharifi, S., Dzik, W.H. & Sadrzadeh, S.M. (2000) Human plasma and tirilazad mesylate protect stored human erythrocytes against the oxidative damage of gamma-irradiation. Transfusion Medicine (Oxford, England), 10, 125-130.
78. Shaz, B.H., James, A.B., Demmons, D.G., Schreiber, G.B. & Hillyer, C.D. (2010) The African American church as a donation site: motivations and barriers. Transfusion, 50, 1240-1248.
79. Shih-Ching, K., Choudhry, M.A., Matsutani, T., Schwacha, M.G., Rue, L.W., Bland, K.I. & Chaudry, I.H. (2004) Splenectomy differentially influences immune responses in various tissue compartments of the body. Cytokine, 28, 101-108.
80. Singer, S.T., Wu, V., Mignacca, R., Kuypers, F.A., Morel, P. & Vichinsky, E.P. (2000) Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly asian descent. Blood, 96, 3369-3373.
81. Singleton, B.K., Green, C.A., Avent, N.D., Martin, P.G., Smart, E., Daka, A., Narter-Olaga, E.G., Hawthorne, L.M. & Daniels, G. (2000) The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in africans with the Rh D-negative blood group phenotype. Blood, 95, 12-18.
82. Sirchia, G., Zanella, A., Parravicini, A., Morelati, F., Rebulla, P. & Masera, G. (1985) Red cell alloantibodies in thalassemia major. Results of an Italian cooperative study. Transfusion, 25, 110-112.
83. Spanos, T., Karageorga, M., Ladis, V., Peristeri, J., Hatziliami, A. & Kattamis, C. (1990) Red cell alloantibodies in patients with thalassemia. Vox Sanguinis, 58, 50-55.
84. Spinella, P.C., Dressler, A., Tucci, M., Carroll, C.L., Rosen, R.S., Hume, H., Sloan, S.R. & Lacroix, J. (2010) Survey of transfusion policies at US and Canadian children's hospitals in 2008 and 2009. Transfusion, 50, 2328-2335.
85. Squires, J.E., Larison, P.J., Charles, W.T. & Milner, P.F. (1985) A delayed hemolytic transfusion reaction due to anti-Cob. Transfusion, 25, 137-139.
86. Suzuki, Y., Tateishi, N., Cicha, I., Shiba, M., Muraoka, M., Tadokoro, K. & Maeda, N. (2000) Decreased deformability of the X-ray-irradiated red blood cells stored in mannitol-adenine-phosphate medium. Clinical Hemorheology and Microcirculation, 22, 131-141.
87. Tahhan, H.R., Holbrook, C.T., Braddy, L.R., Brewer, L.D. & Christie, J.D. (1994) Antigen-matched donor blood in the transfusion management of patients with sickle cell disease. Transfusion, 34, 562-569.
88. Talano, J.A., Hillery, C.A., Gottschall, J.L., Baylerian, D.M. & Scott, J.P. (2003) Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease. Pediatrics, 111, e661-e665.
89. Tatari-Calderone, Z., Minniti, C.P., Kratovil, T., Stojakovic, M., Vollmer, A., Barjaktarevic, I., Zhang, E., Hoang, A., Luban, N.L. & Vukmanovic, S. (2009) rs660 polymorphism in Ro52 (SSA1; TRIM21) is a marker for age-dependent tolerance induction and efficiency of alloimmunization in sickle cell disease. Molecular Immunology, 47, 64-70.
90. Thompson, A.A., Cunningham, M.J., Singer, S.T., Neufeld, E.J., Vichinsky, E., Yamashita, R., Giardina, P., Kim, H.Y., Trachtenberg, F. & Kwiatkowski, J.L. (2011) Red cell alloimmunization in a diverse population of transfused patients with thalassaemia. British Journal of Haematology, 153, 121-128.
91. Thuret, I., Pondarre, C., Loundou, A., Steschenko, D., Girot, R., Bachir, D., Rose, C., Barlogis, V., Donadieu, J., de Montalembert, M., Hagege, I., Pegourie, B., Berger, C., Micheau, M., Bernaudin, F., Leblanc, T., Lutz, L., Galacteros, F., Simeoni, M.C. & Badens, C. (2010) Complications and treatment of patients with beta-thalassemia in France: results of the National Registry. Haematologica, 95, 724-729.
92. Toly-Ndour, C., Rouquette, A.M., Obadia, S., M'Bappe, P., Lionnet, F., Hagege, I., Boussa-Khettab, F., Tshilolo, L. & Girot, R. (2011) High titers of autoantibodies in patients with sickle-cell disease. Journal of Rheumatology, 38, 302-309.
93. Tournamille, C., Meunier-Costes, N., Costes, B., Martret, J., Barrault, A., Gauthier, P., Galacteros, F., Nzouekou, R., Bierling, P. & Noizat-Pirenne, F. (2010) Partial C antigen in sickle cell disease patients: clinical relevance and prevention of alloimmunization. Transfusion, 50, 13-19.
94. Triulzi, D.J. & Yazer, M.H. (2010) Clinical studies of the effect of blood storage on patient outcomes. Transfusion and Apheresis Science, 43, 95-106.
95. Vamvakas, E.C. & Carven, J.H. (2000) Length of storage of transfused red cells and postoperative morbidity in patients undergoing coronary artery bypass graft surgery. Transfusion, 40, 101-109.
96. Vege, S. & Westhoff, C.M. (2006) Molecular characterization of GYPB and RH in donors in the American Rare Donor Program. Immunohematology, 22, 143-147.
97. Veldhuisen, B., van der Schoot, C.E. & de Haas, M. (2009) Blood group genotyping: from patient to high-throughput donor screening. Vox Sanguinis, 97, 198-206.
98. Venkateswaran, L., Teruya, J., Bustillos, C., Mahoney, Jr, D. & Mueller, B.U. (2011) Red cell exchange does not appear to increase the rate of allo- and auto-immunization in chronically transfused children with sickle cell disease. Pediatric Blood & Cancer, 57, 294-296.
99. Vichinsky, E. (2001a) Consensus document for transfusion-related iron overload. Seminars in Hematology, 38, 2-4.
100. Vichinsky, E.P. (2001b) Current issues with blood transfusions in sickle cell disease. Seminars in Hematology, 38, 14-22.
101. Vichinsky, E.P., Earles, A., Johnson, R.A., Hoag, M.S., Williams, A. & Lubin, B. (1990) Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. New England Journal of Medicine, 322, 1617-1621.
102. Vichinsky, E.P., Luban, N.L., Wright, E., Olivieri, N., Driscoll, C., Pegelow, C.H. & Adams, R.J. (2001) Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion, 41, 1086-1092.
103. Wang, L.Y., Liang, D.C., Liu, H.C., Chang, F.C., Wang, C.L., Chan, Y.S. & Lin, M. (2006) Alloimmunization among patients with transfusion-dependent thalassemia in Taiwan. Transfusion Medicine (Oxford, England), 16, 200-203.
104. Wilkinson, K., Harris, S., Gaur, P., Haile, A., Armour, R., Teramura, G. & Delaney, M. (2012) Molecular blood typing augments serologic testing and allows for enhanced matching of red blood cells for transfusion in patients with sickle cell disease. Transfusion, 52, 381-388.
105. Win, N., Sinha, S., Lee, E. & Mills, W. (2010) Treatment with intravenous immunoglobulin and steroids may correct severe anemia in hyperhemolytic transfusion reactions: case report and literature review. Transfusion Medicine Reviews, 24, 64-67.
106. Yardumian, A., Telfer, P. & Darbyshire, P. (2008) Standards for the Clinical Care of Children and Adults with Thalassaaemia in the UK, 2nd edn. Thalassaemia Society, London, UK. http://www.ukts.org/pdfs/awareness/standards/ukts-standards-2008.pdf.
107. Yazer, M.H. & Triulzi, D.J. (2010) Receipt of older RBCs does not predispose D-negative recipients to anti-D alloimmunization. Am J Clin Pathol, 134, 443-447.